Submissions

1 SCOPE

The Journal of Applied Oral Science (JAOS) it is committed to publishing the scientific and technological advances achieved by the orofacial, dental and speech-language pathology and audiology communities, according to the quality indicators and peer-reviewed material, with the objective of assuring its acceptability within its knowledge fields. The primary goal of JAOS is to publish the outcomes of original research/clinical investigations in the field of Oral Sciences, with emphasis in dentistry, speech-language pathology and audiology, and related areas.

Submissions of case reports (including case series and clinical protocols) and short communication  are no longer accepted by JAOS and review manuscripts (including systematic reviews) can only be submitted under the editor's invitation.

This Journal adopts Creative Commons license CC-BY:

"This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials."

1.1 Publication fee

There is no fee to authors for submitting to JAOS nor Article Processing Charge (APC).

2 GENERAL GUIDELINES

2.1 Originality

The papers sent for publication must be original and the simultaneous submission to another journal, either natioEnal or international, is not allowed. JAOS shall retain the copyright of all papers published, including translations; future reproduction as a transcription are also allowed, provided the source is properly mentioned.

2.2 Acceptance of preprints

A preprint is defined as a manuscript ready for submission to a journal that is deposited on trusted preprint servers before or in parallel with submission to a journal. Submissions of papers previously deposited on these servers will be accepted, which will be duly evaluated for their recognition and quality by JAOS.

In case of acceptance and publication of the article in JAOS, the authors must update the registration status on the preprint server, informing the complete reference of the publication in the journal.

2.3 Data repository

JAOS requires the citation and referencing of data, program codes and any other underlying contents of the texts of the articles. Papers resulting from original research projects must be submitted with a footnote on the cover page about data availability, stating whether the dataset is publicly available or not, and how to access it.

To ensure full transparency of the data obtained, JAOS requires authors to declare that any piece of data that is not deposited in open access repositories must be made available to reviewers upon request.

To make these data available in accordance with SciELO’s policies, authors must fill in the Open Science Compliance form.

To ensure the quality and recognition of the data generated, JAOS recommends and follows the FAIR principles (Findable, Accessible, Interoperable and Reusable).

JAOS recommends the following data repositories:

SciELO Data - https://data.scielo.org/
Figshare - https://figshare.com/
Havard Dataverse - https://dataverse.harvard.edu/
Data Mendley - https://data.mendeley.com/
Zenodo - https://zenodo.org/
Repositório de dados científicos da USP - https://uspdigital.usp.br/repositorio/

2.4 JAOS will only accept submissions of manuscripts written in English. The English language should also be adopted in all documents during the procedures involving the articles. The content of the texts, quotations and references of the papers submitted and published are of the sole responsibility of the authors, not necessarily reflecting the opinion of JAOS’s Editor-in-Chief or Editorial Board.

2.5 JAOS has the right to submit all manuscripts to the Editorial Board, which is fully authorized to determine the appropriateness of their content to peer review (otherwise, manuscripts will receive an Immediate Rejection decision), and the subsequent decision regarding acceptance/rejection, or return them to the authors with suggestions and modifications to the text and/or for them to adapt it to the editorial standards of the journal. In this case, the manuscript will be reevaluated by the Editor-in-Chief and the Editorial Board.

2.6 The dates of receipt of the original article and its acceptance will appear when published in the JAOS.

2.7 JAOS is published exclusively in electronic format.

3 REFEREEING CRITERIA

3.1 Pre-evaluation: manuscripts will be appreciated by Editors-in-Chief and Associate Editors for their adequacy to the Journal’s scope, priority and potential publication and citation impact, degree of novelty and methodology. Manuscripts considered inadequate at this step will be rejected and returned to authors, while the manuscripts considered adequate will follow the regular peer review process.

3.2 Technical review: manuscripts approved in the pre-evaluation stage will be then evaluated for their compliance to the publication norms and presence of mandatory documents required for submission to JAOS. Manuscripts not in accordance with instructions will be returned to authors for adjustments before being reviewed by Associate Editors and referees.

3.3 Merit and content evaluation: papers approved by Associate Editors will be evaluated in their scientific merit and methods by at least two ad hoc referees from different institutions of that of the authors, besides the Editor-in-Chief.

3.3.1 As part of the evaluation process, all manuscripts will be submitted to analysis by a plagiarism software.

3.3.2 The Editor-in-Chief will decide on manuscript acceptance. When revision of the original is required, the manuscript will be returned to the corresponding author for modification. A revised version with modifications will be re-submitted by the authors, and that will be re-evaluated by the Editor-in-Chief, Editorial Board and ad hoc referees, if necessary.

3.4 After approval of the scientific merit, manuscripts will pass through a final review performed by a professional assigned by JAOS. If manuscripts are still considered inadequate, they will be returned to authors for revision.

3.5 Authors and referees will be kept anonymous during the review process.

4 GALLEY PROOFS

4.1 Galley proofs of each article will be sent to the corresponding author by electronic mail in pdf format for final approval.

4.2 If necessary, authors will have 48 hours to make corrections and return the revised article.

4.3 The only corrections accepted will be minor spelling corrections and the verification of figures. Major corrections will cause the manuscript to undergo a new revision by referees and delay in its publication.

4.4 If the galley proof is not returned in 48 hours, the Editor-in-Chief will consider it the unchanged final version.

4.5 Inclusion of new authors is not allowed at this stage of the publication process.

4.6 It is the sole responsibility of the authors to verify the proper use of their citation names and affiliation in the manuscript.

1 PRESENTATION OF THE MANUSCRIPT

1.1 Structure of the manuscript

1.1.1 Cover page must be submitted as a supplementary file and should contain only:

•  Title of the manuscript in English.
•  Names of the authors in direct order with their respective affiliations in English. Affiliations must be written in Portuguese for Brazilian authors, in Spanish for Spanish authors, and in English for the other nationalities.
•  Full address of the corresponding author, to whom all correspondence should be addressed, including phone number as well as e-mail address.
•  Information about the deposit of the manuscript on a preprints server, when applicable, indicating the access address and DOI number, if required (attach the Open Science Compliance form). Citation and referencing of the research data specifying the repository and the DOI number (attach the Open Science Compliance form).
•  Mandatory note stating whether the manuscript is derived from any dissertations or theses and their respective access address when available.

1.1.2 Text

•  The paper must be previously translated into English language or proofread by a copyediting professional or company.
  Authors with English as native language must submit as supplementary file a signed letter taking responsibility for the quality of the English language and editing of the text.
•  Title of the manuscript in English.
•  Abstract structured in a sole paragraph: should comprise at most 300 words, highlighting a little introduction, objective, methodology, results and conclusions.
•  Keywords: words or expressions that identify the contents of the manuscript. The authors must check both MeSH and DeCS. Authors must use periods to separate the keywords, which must have the first letter of the first word in capital letters. Ex: Dental implants. Fixed prosthesis. Photoelasticity. Passive fit.
•  Introduction: summary of the rationale and proposal of the study including only proper references. It should clearly state the hypothesis of the study.
•  Methodology: the material and the methods are presented with enough detail to allow confirmation of the findings. Include the city, state and country of all manufacturers right after the first appearance of the products, reagents or equipments. Published methods should be referred to and briefly discussed, except if modifications were made. Indicate the statistical methods employed, if applicable. Please refer to item 3 for ethical principals and registration of clinical trials.
•  Results: must be presented in a logical sequence in the text, tables and illustrations. Data contained in tables and illustrations should not be repeated in the text, and only important findings should be highlighted. Please, use the fewest number tables and figures possible.
•  Discussion: this section should emphasize the new and important aspects of the study, discussing them with prior investigations. Any data or information mentioned in the introduction or results should not be repeated.The authors should stress the implications of their findings, as well as their limitations.
•  Conclusion(s): Provide short conclusions that can be taken from the research. Go further than reaffirming the results, establishing relevant conclusions to the objectives based on the data. In most cases, the conclusions are only true for the study population.
•  Acknowledgments (when appropriate): Acknowledge those who have contributed to the work. Specify sponsors, grants, scholarships and fellowships with respective names and identification numbers.
•  References (please refer to item 2.3)

2 TECHNICAL NORMALIZATION

The text body of the manuscript should be typed as follows: 1.5 spacing in 11 pt Arial font, with 3-cm margins at each side, on an A4 page, adding up, to at most, 12 pages, thus excluding figures, tables, figure legends and references.

2.1 Illustrations and Tables

2.1.1 The illustrations (photographs, graphs, drawings, charts, etc.), regarded as figures, should be limited to the least amount possible and should be uploaded in separate files, consecutively numbered with Arabic numbers according to the order they appear in the text.

2.1.2 All illustrations must be inserted in the body of the Word file but sent separately as individual files during the submission of the article. Photographs should be sent in .jpg format with at least 10 cm width and at least 300 dpi.

2.1.3 The tables should be logically arranged, consecutively numbered with Arabic numbers. The legend shall be placed above the tables. Tables should be open in the right and left laterals, removing any internal horizontal or vertical lines, as well as any colors or shades. Tables must be sent in .xls format.

2.1.4 The corresponding legends for figures and tables should be clear, concise and typed at the end of the manuscript as a separate list preceded by the corresponding number.

2.1.5 Footnotes should be indicated by asterisks and restricted to the least amount possible.

2.2 Citation of the Authors

Citation of the authors in the text may be performed in two manners:

1) Just numeric: ...and interfere with the bacterial system and tissue system.^3,4,7-10 

References must be cited in a numeric ascending order within the paragraph.

2) or alphanumeric

•  one author - Gatewood³¹ (2012)
•  two authors - Cotti and Mercuro¹⁹ (2016)
•  three authors - Azar, Safi, Nikaein²⁷ (2012)
•  more than three authors - Gealh, et al.²⁸ (2014)

2.3 References

The references must follow the "Uniform requirements for manuscripts submitted to Biomedical Journals - Vancouver" available at: http://www.nlm.nih.gov/bsd/uniform_requirements.html.

2.3.1 All references must be cited in the text. They should be numbered consecutively in the order in which they are first mentioned in the text. Abbreviations of the titles of the journals cited should follow MEDLINE.

2.3.2 Personal communications and unpublished data with no publication date must not be included in the reference list.

2.3.3 Abstracts, monographs, dissertations and theses will not be accepted as references.

2.3.4 Avoid referencing articles published in languages other than English (if included, limit them to a maximum of 3). The English translation of the title must appear between brackets and the original title by the end of the reference.

2.3.5 The names of all authors should be cited up to 6 authors; in case there are more authors, the 6 first authors should be cited, followed by the expression ", et al.", which must be followed by period and should not be written in italics. Ex: Cintra LT, Samuel RO, Azuma MM, Ribeiro CP, Narciso LG, Lima VM, et al.

2.3.6 At most 40 references may be cited.

Examples of references:

Book

Preedy VR, organizator. Fluorine: chemistry, analysis, function and effects. London: Royal Society of Chemistry; 2015.

Book chapter

Buzalaf CP, Leite AL, Buzalaf MA. Fluoride metabolism. In: Preedy VR, organizator. Fluorine: chemistry, analysis, function and effects. London: Royal Society of Chemistry; 2015. p. 54-72.

Papers published in journals

Gorduysus M, Nagas E, Torun OY, Gorduysus O. A comparison of three rotary systems and hand instrumentation technique for the elimination of Enterococcus faecalis from the root canal. Aust Endod J. 2011;37(3):128-33.

Papers published in journals in languages other than English

Merz WA. Die Streckenmessung an gerichteten Strukturen im Mikroskop und ihre Anwendung zur Bestimmung von Oberflächen-Volumen-Relationen im Knochengewebe [Distance measurement of directed structures in the microscope and its use in the determination of surface and volume relationship in bone tissue]. Mikroskopie. 1968;22(5):132-42. German

Online-only journal article (with electronic identifier)

Rudolph H, Ostertag S, Ostertag M, Walter MH, Luthardt RG, Kuhn K. Reliability of light microscopy and a computer-assisted replica measurement technique for evaluating the fit of dental copings. J Appl Oral Sci [Internet]. 2018[cited 2017 Dec 12];26:e20160590. Available from: http://dx.doi.org/10.1590/1678-7757-2016-0590

Journal article with DOI

Wagner F, Strasz M, Traxler H, Schicho K, Seemann R. Evaluation of an experimental oblique plate for osteosynthesis of mandibular condyle fractures. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124(6):537-41. doi: 10.1016/j.oooo.2017.09.004

Journal article Epub ahead of print/In press/Forthcoming

Cavalla F, Letra A, Silva RM, Garlet GP. Determinants of periodontal/periapical lesion stability and progression. J Dent Res. Forthcoming 2020. doi: 10.1177/0022034520952341

Preprint

Weissheimer T, Só MV, Alcalde MP, Cortez JB, Rosa RA, Vivan RR, et al. Evaluation of mechanical properties of coronal flaring nickel-titanium instruments. Research Square rs-49258/v1 [Preprint]. 2020 [cited 2020 Sept 2]. Available from: https://doi.org/10.21203/rs.3.rs-49258/v1

Research data

Mazzi-Chaves JF, Silva-Sousa YT, Leoni GB, Silva-Sousa AC, Estrela L, Estrela C, et al. Micro-computed tomographic assessment of the variability and morphological features of root canal system and their ramifications [dataset]. 2020 Feb 11 [cited 2020 Sept 2]. In: figshare [Internet]. London: Digital Science. 416.15 KB. Available from: https://doi.org/10.6084/m9.figshare.11839527.v1

Papers with more than 6 authors

The first 6 authors are cited, followed by the expression ", et al."

Grubbs V, Plantinga LC, Crews DC, Bibbins-Domingo K, Saran R, Heung M, et al. Vulnerable populations and the association between periodontal and chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:711-7

Volume with supplement and/or Special Issue

Davisdson CL. Advances in glass-ionomer cements. J Appl Oral Sci. 2006;14(sp. Issue):3-9.

The authors are fully responsible for the correctness of the references.

3 ETHICAL PRINCIPLES AND REGISTRATION OF CLINICAL TRIALS

3.1 Experimental procedures in humans and animals

JAOS reassures the principles incorporated in the Helsinky Declaration and insists that all research involving human beings, in the event of publication in this journal, be conducted in conformity with such principles and others specified in the respective ethics committees of authors’ institution. In the case of experiments with animals, the same ethical principles must also be followed. When surgical procedures in animals were used, the authors should present, in the Methodology section, evidence that the dose of a proper substance was adequate to produce anesthesia during the entire surgical procedure. All experiments conducted in human or animals must accompany a description, in the Methodology section, that the study was approved by the respective Ethics Committee of authors’ affiliation and provide the number of the protocol approval.

3.1.1 Papers presenting experimentalstudies in human volunteers or in animals must contain the Ethical Committee approval of the reports as mandatory supplementary file.

3.1.2 Papers describing studies in animals must be submitted with the ARRIVE Checklist as mandatory supplementary file. The ARRIVE Checklist is available at

https://mc04.manuscriptcentral.com/societyimages/jaos-scielo/ARRIVEChecklist.docx

3.1.3 Ethics Committee certificate written in different languages from English, Spanish and Portuguese must be full translated into English.

3.2 Clinical Trial Registration

JAOS supports the policies of the World Health Organization (WHO) and the International Committee of Medical Journal Editors (ICMJE) for the registration of clinical trials. The journal recognizes the importance of such initiatives for the registration and international publication of clinical studies with an open access. Therefore, JAOS will publish only those clinical trials that have previously received an identification number validated by the criteria established by the WHO and ICMJE.

The WHO defines clinical trials as "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, preventive care, etc".

3.2.1 Manuscripts presenting clinical trials in human volunteers must be submitted with the following mandatory supplementary files:

•  CONSORT 2010 checklist;
•  registration number of the research in a database that meets the requirements of the WHO and the ICMJE
•  Suggestions: for Brazilian authors
•  Suggestions for Brazilian and non-Brazilian authors/ (ISRCTN).

3.2.2 Survey-based studies must be submitted following the same instructions of the item above.

3.3 Systematic Reviews

Systematic Reviews SHOULD ONLY BE SUBMITTED AT THE INVITATION OF JAOS. And even in these cases, JAOS will only receive Systematic Reviews of any kind (Traditional, Overviews, Umbrella Reviews and Scoping Reviews) if they meet 2 mandatory requirements:

•  The prior publication of the research protocol of the Systematic Review in a scientific journal or the proof of the prior registration number of the Systematic Review protocol in a specific online platform for this purpose. Submissions with a registration date from after the date of submission of the article to JAOS will not be accepted. For registering the Systematic Review, the following platforms are suggested:
•  PROSPERO International Prospective Register of Systematic Reviews)
•  Open Science Framework
•  Joanna Briggs Institute 
•  Cochrane Library 
•  Duly filled PRISMA Checklist, including all applicable extensions for particular cases.

3.4 The Editor-in-Chief and the Editorial Board reserve the right to refuse manuscripts that show no clear evidence that the methods used were not appropriate for experiments in humans or animals.

4 ANY FURTHER QUERIES SHALL BE SOLVED BY THE Editor-in-Chief AND EDITORIAL BOARD

1 MANUSCRIPT SUBMISSION

1.1 Articles must be submitted through the following address https://mc04.manuscriptcentral.com/jaos-scielo

1.2 The original file containing the main manuscript must be submitted without the author’s’ identification and affiliations.

1.3 The cover page must be submitted as a supplementary file containing the names of the authors, affiliations and correspondence address, citation and reference of the data repository and preprint server used (when appropriate) and the obligatory note for when the manuscript is derived from a dissertation/thesis.

1.4 Figures must be submitted as supplementary files according to the specifications of item 2.1 regarding the form and preparation of manuscripts.

1.5 Tables must be prepared in Excel format and must be submitted as a supplementary files.

1.6 Documents for proof – Ethics Committee protocol, Clinical trial registration, CONSORT Checklist, ARRIVE Checklist and PROSPERO registration – must be submitted as mandatory files.

1.7 The copyediting certificate for English language (signed by a professional or editing company) must be submitted as mandatory supplementary file.

1.8 The submission form, signed by ALL authors, must be submitted as a mandatory file.

1.9 The Open Science Compliance Form MUST be submitted as a supplementary file.

1.10 JAOS requires the inclusion of the ORCID registration number of the authors for manuscript submission. All authors must associate the ORCID registration number to their profile on ScholarOne.